ArticleEmerging infectious diseases2016
Initial Costs of Ebola Treatment Centers in the United States.
Article in Emerging infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Preparedness and Response Considerations for High-Consequence Infectious Disease.Emerging infectious diseases · 2025Review
- Institutional readiness to provide critical care to patients with viral hemorrhagic fever (VHF) in the United States after the COVID-19 pandemic.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025Article
- Zero tolerance for complacency by government of West African countries in the face of COVID-19.Human antibodies · 2021Review
- A Canary in a COVID Coal Mine: Building Better Healthcare Biopreparedness Policy.World medical & health policy · 2020Article
- Update on Ebola Treatment Center Costs and Sustainability, United States, 2019.Emerging infectious diseases · 2020Article
- A Methodology for Determining Which Diseases Warrant Care in a High-Level Containment Care Unit.Viruses · 2019Article
- Ebola Virus Disease Preparations Do Not Protect the United States Against Other Infectious Outbreaks.American journal of public health · 2018Article
- Ebola in the Netherlands, 2014-2015: costs of preparedness and response.The European journal of health economics : HEPAC : health economics in prevention and care · 2018Article
- U.S. High-Level Isolation Unit Clinical Laboratory Capabilities Update.Journal of clinical microbiology · 2018Article
- High-Containment Pathogen Preparation in the Intensive Care Unit.Infectious disease clinics of North America · 2017Review
- Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers.Emerging infectious diseases · 2017Article
- The Vital Case for Global Health Investments by the US Government.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017Article
- COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious DiseasesObservational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.